Author:
Benschop Robert,Wei Tao,Na Songqing
Reference22 articles.
1. Hsu HC, Wu Y, Mountz JD. Tumor necrosis factor ligand-receptor superfamily and arthritis. Curr Dir Autoimmun 2006; 9:37–54.
2. Nash PT, Florin TH. Tumour necrosis factor inhibitors. Med J Aust 2005; 183:205–8.
3. Tanaka S, Nakamura K, Takahasi N et al. Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system. Immunol Rev 2005; 208:30–49.
4. van Horssen R, ten Hagen TL, Eggermont AM. TNF-alpha in cancer treatment: molecular insights, antitumor effects and clinical utility. Oncologist 2006; 11:397–408.
5. Lejeune FJ, Lienard D, Matter M et al. Efficiency of recombinant human TNF in human cancer therapy: Cancer Immun 2002; 6:6–22.